Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Assessing Medical Technologies (1985) (ISBN 030903583X) Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention


• Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (2010) (ISBN 0309153328) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Redesigning the Clinical Effectiveness Research Paradigm:Innovation and Practice-Based Approaches: Workshop Summary (2010) (ISBN 030911988X) LeighAnne Olsen and J. Michael McGinnis; Roundtable on Value & Science-Driven Health Care; Institute of Medicine


• Technological Innovation: Comparing Development of Drugs, Devices, and Procedures in Medicine, Background Paper (1989) (ISBN NI000288)


• The Prevention and Treatment of Missing Data in Clinical Trials (2010) (ISBN 0309158141) Panel on Handling Missing Data in Clinical Trials; National Research Council


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Patient Outcomes Research Teams (PORTS):Managing Conflict of Interest (1991) (ISBN 0309044820) Molla S. Donaldson and Alexander M. Capron, Editors; Committee on Potential Conflicts of Interest in Patient Outcomes Research Teams, Institute of Medicine


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (2009) (ISBN 030911053X) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Adopting New Medical Technology (1994) (ISBN 0309050359) Annetine C. Gelijns and Holly V. Dawkins, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• Preventing Medication Errors: Quality Chasm Series (2007) (ISBN 0309101476) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Extending Medicare Reimbursement in Clinical Trials (2000) (ISBN 0309068886) Henry J. Aaron and Hellen Gelband, Editors; Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (2011) (ISBN 0309219299) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Medical Technology Assessment Directory:A Pilot Reference to Organizations, Assessments, and Information Resources (1988) (ISBN 0309038294) Council on Health Care Technology